Global Oral Solid Dosage (OSD) Contract Manufacturing Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	169 Pages	TechNavio	August, 2024	INF19175999

Best Price Guarantee
Price	from $2,500
Length	169 Pages
Publisher	TechNavio
Published Date	August, 2024
SKU	INF19175999

Global Oral Solid Dosage (OSD) Contract Manufacturing Market 2024-2028

The oral solid dosage (OSD) contract manufacturing market is forecasted to grow by USD 14.2 bn during 2023-2028, accelerating at a CAGR of 6.84% during the forecast period. The report on the oral solid dosage (OSD) contract manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by patent expiry and increasing demand for generic drugs, growing need to focus on core competencies, and availability of cost-efficient resources in emerging markets.

Technavio's oral solid dosage (OSD) contract manufacturing market is segmented as below:

By End-user

Large-size companies
Small and medium size companies
Startups and generic pharmaceutical companies

By Product

Tablets
Capsules
Powders
Granules and others

By Geographical Landscape

Asia
North America
Europe
Rest of World (ROW)

This study identifies the increasing number of US FDA-approved manufacturing facilities as one of the prime reasons driving the oral solid dosage (OSD) contract manufacturing market growth during the next few years. Also, growing use of analytics by cmos that manufacture OSD and increasing market consolidation will lead to sizable demand in the market.

The report on the oral solid dosage (OSD) contract manufacturing market covers the following areas:

Oral solid dosage (OSD) contract manufacturing market sizing
Oral solid dosage (OSD) contract manufacturing market forecast
Oral solid dosage (OSD) contract manufacturing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oral solid dosage (OSD) contract manufacturing market vendors that include AbbVie Inc., Acino International AG, Aenova Holding GmbH, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, Catalent Inc., Corden Pharma International GmbH, Inglasia Pharma Solutions, Jubilant Pharmova Ltd., Koninklijke DSM NV, Lonza Group Ltd., Merck KGaA, NextPharma GmbH, Perkin Elmer Inc., Piramal Enterprises Ltd., Pyramid Laboratories Inc., Recipharm AB, Siegfried Holding AG, Thermo Fisher Scientific Inc., and Viatris Inc.. Also, the oral solid dosage (OSD) contract manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ billion); Data Table on Global - Market size and forecast 2023-2028 ($ billion); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Oral Solid Dosage (OSD) Contract Manufacturing Market 2018 - 2022; Historic Market Size - Data Table on Global Oral Solid Dosage (OSD) Contract Manufacturing Market 2018 - 2022 ($ billion); 4.2 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ billion); 4.3 Product segment analysis 2018 - 2022; Historic Market Size - Product Segment 2018 - 2022 ($ billion); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ billion); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 6.3 Large-size companies - Market size and forecast 2023-2028; Chart on Large-size companies - Market size and forecast 2023-2028 ($ billion); Data Table on Large-size companies - Market size and forecast 2023-2028 ($ billion); Chart on Large-size companies - Year-over-year growth 2023-2028 (%); Data Table on Large-size companies - Year-over-year growth 2023-2028 (%); 6.4 Small and medium size companies - Market size and forecast 2023-2028; Chart on Small and medium size companies - Market size and forecast 2023-2028 ($ billion); Data Table on Small and medium size companies - Market size and forecast 2023-2028 ($ billion); Chart on Small and medium size companies - Year-over-year growth 2023-2028 (%); Data Table on Small and medium size companies - Year-over-year growth 2023-2028 (%); 6.5 Startups and generic pharmaceutical companies - Market size and forecast 2023-2028; Chart on Startups and generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion); Data Table on Startups and generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion); Chart on Startups and generic pharmaceutical companies - Year-over-year growth 2023-2028 (%); Data Table on Startups and generic pharmaceutical companies - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by End-user; Market opportunity by End-user ($ billion); Data Table on Market opportunity by End-user ($ billion)
7 Market Segmentation by Product: 7.1 Market segments; Chart on Product - Market share 2023-2028 (%); Data Table on Product - Market share 2023-2028 (%); 7.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 7.3 Tablets - Market size and forecast 2023-2028; Chart on Tablets - Market size and forecast 2023-2028 ($ billion); Data Table on Tablets - Market size and forecast 2023-2028 ($ billion); Chart on Tablets - Year-over-year growth 2023-2028 (%); Data Table on Tablets - Year-over-year growth 2023-2028 (%); 7.4 Capsules - Market size and forecast 2023-2028; Chart on Capsules - Market size and forecast 2023-2028 ($ billion); Data Table on Capsules - Market size and forecast 2023-2028 ($ billion); Chart on Capsules - Year-over-year growth 2023-2028 (%); Data Table on Capsules - Year-over-year growth 2023-2028 (%); 7.5 Powders - Market size and forecast 2023-2028; Chart on Powders - Market size and forecast 2023-2028 ($ billion); Data Table on Powders - Market size and forecast 2023-2028 ($ billion); Chart on Powders - Year-over-year growth 2023-2028 (%); Data Table on Powders - Year-over-year growth 2023-2028 (%); 7.6 Granules and others - Market size and forecast 2023-2028; Chart on Granules and others - Market size and forecast 2023-2028 ($ billion); Data Table on Granules and others - Market size and forecast 2023-2028 ($ billion); Chart on Granules and others - Year-over-year growth 2023-2028 (%); Data Table on Granules and others - Year-over-year growth 2023-2028 (%); 7.7 Market opportunity by Product; Market opportunity by Product ($ billion); Data Table on Market opportunity by Product ($ billion)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ billion); Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.4 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ billion); Data Table on North America - Market size and forecast 2023-2028 ($ billion); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.5 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ billion); Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ billion); Data Table on China - Market size and forecast 2023-2028 ($ billion); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.8 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ billion); Data Table on US - Market size and forecast 2023-2028 ($ billion); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.9 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ billion); Data Table on Japan - Market size and forecast 2023-2028 ($ billion); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.10 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ billion); Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.11 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ billion); Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ billion); Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; 12.4 Aenova Holding GmbH; Aenova Holding GmbH - Overview; Aenova Holding GmbH - Product / Service; Aenova Holding GmbH - Key offerings; 12.5 Boehringer Ingelheim International GmbH; Boehringer Ingelheim International GmbH - Overview; Boehringer Ingelheim International GmbH - Product / Service; Boehringer Ingelheim International GmbH - Key news; Boehringer Ingelheim International GmbH - Key offerings; 12.6 Catalent Inc.; Catalent Inc. - Overview; Catalent Inc. - Business segments; Catalent Inc. - Key offerings; Catalent Inc. - Segment focus; 12.7 Corden Pharma International GmbH; Corden Pharma International GmbH - Overview; Corden Pharma International GmbH - Product / Service; Corden Pharma International GmbH - Key offerings; 12.8 Jubilant Pharmova Ltd.; Jubilant Pharmova Ltd. - Overview; Jubilant Pharmova Ltd. - Business segments; Jubilant Pharmova Ltd. - Key news; Jubilant Pharmova Ltd. - Key offerings; Jubilant Pharmova Ltd. - Segment focus; 12.9 Lonza Group Ltd.; Lonza Group Ltd. - Overview; Lonza Group Ltd. - Business segments; Lonza Group Ltd. - Key news; Lonza Group Ltd. - Key offerings; Lonza Group Ltd. - Segment focus; 12.10 Merck KGaA; Merck KGaA - Overview; Merck KGaA - Business segments; Merck KGaA - Key news; Merck KGaA - Key offerings; Merck KGaA - Segment focus; 12.11 NextPharma GmbH; NextPharma GmbH - Overview; NextPharma GmbH - Product / Service; NextPharma GmbH - Key offerings; 12.12 Perkin Elmer Inc.; Perkin Elmer Inc. - Overview; Perkin Elmer Inc. - Business segments; Perkin Elmer Inc. - Key news; Perkin Elmer Inc. - Key offerings; Perkin Elmer Inc. - Segment focus; 12.13 Piramal Enterprises Ltd.; Piramal Enterprises Ltd. - Overview; Piramal Enterprises Ltd. - Product / Service; Piramal Enterprises Ltd. - Key offerings; 12.14 Pyramid Laboratories Inc.; Pyramid Laboratories Inc. - Overview; Pyramid Laboratories Inc. - Product / Service; Pyramid Laboratories Inc. - Key offerings; 12.15 Recipharm AB; Recipharm AB - Overview; Recipharm AB - Business segments; Recipharm AB - Key offerings; Recipharm AB - Segment focus; 12.16 Siegfried Holding AG; Siegfried Holding AG - Overview; Siegfried Holding AG - Business segments; Siegfried Holding AG - Key offerings; Siegfried Holding AG - Segment focus; 12.17 Thermo Fisher Scientific Inc.; Thermo Fisher Scientific Inc. - Overview; Thermo Fisher Scientific Inc. - Business segments; Thermo Fisher Scientific Inc. - Key news; Thermo Fisher Scientific Inc. - Key offerings; Thermo Fisher Scientific Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Product; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Oral Solid Dosage (OSD) Contract Manufacturing Market 2018 - 2022 ($ billion); Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ billion); Exhibits22: Historic Market Size - Product Segment 2018 - 2022 ($ billion); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on End-user - Market share 2023-2028 (%); Exhibits33: Data Table on End-user - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by End-user; Exhibits35: Data Table on Comparison by End-user; Exhibits36: Chart on Large-size companies - Market size and forecast 2023-2028 ($ billion); Exhibits37: Data Table on Large-size companies - Market size and forecast 2023-2028 ($ billion); Exhibits38: Chart on Large-size companies - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Large-size companies - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Small and medium size companies - Market size and forecast 2023-2028 ($ billion); Exhibits41: Data Table on Small and medium size companies - Market size and forecast 2023-2028 ($ billion); Exhibits42: Chart on Small and medium size companies - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Small and medium size companies - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Startups and generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion); Exhibits45: Data Table on Startups and generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion); Exhibits46: Chart on Startups and generic pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Startups and generic pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits48: Market opportunity by End-user ($ billion); Exhibits49: Data Table on Market opportunity by End-user ($ billion); Exhibits50: Chart on Product - Market share 2023-2028 (%); Exhibits51: Data Table on Product - Market share 2023-2028 (%); Exhibits52: Chart on Comparison by Product; Exhibits53: Data Table on Comparison by Product; Exhibits54: Chart on Tablets - Market size and forecast 2023-2028 ($ billion); Exhibits55: Data Table on Tablets - Market size and forecast 2023-2028 ($ billion); Exhibits56: Chart on Tablets - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Tablets - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Capsules - Market size and forecast 2023-2028 ($ billion); Exhibits59: Data Table on Capsules - Market size and forecast 2023-2028 ($ billion); Exhibits60: Chart on Capsules - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Capsules - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Powders - Market size and forecast 2023-2028 ($ billion); Exhibits63: Data Table on Powders - Market size and forecast 2023-2028 ($ billion); Exhibits64: Chart on Powders - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Powders - Year-over-year growth 2023-2028 (%); Exhibits66: Chart on Granules and others - Market size and forecast 2023-2028 ($ billion); Exhibits67: Data Table on Granules and others - Market size and forecast 2023-2028 ($ billion); Exhibits68: Chart on Granules and others - Year-over-year growth 2023-2028 (%); Exhibits69: Data Table on Granules and others - Year-over-year growth 2023-2028 (%); Exhibits70: Market opportunity by Product ($ billion); Exhibits71: Data Table on Market opportunity by Product ($ billion); Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits73: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits74: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits75: Chart on Geographic comparison; Exhibits76: Data Table on Geographic comparison; Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibits82: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibits83: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits86: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits87: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibits98: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibits99: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on Japan - Market size and forecast 2023-2028 ($ billion); Exhibits102: Data Table on Japan - Market size and forecast 2023-2028 ($ billion); Exhibits103: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits106: Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits107: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits109: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits110: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits111: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits112: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits113: Market opportunity By Geographical Landscape ($ billion); Exhibits114: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits115: Impact of drivers and challenges in 2023 and 2028; Exhibits116: Overview on criticality of inputs and factors of differentiation; Exhibits117: Overview on factors of disruption; Exhibits118: Impact of key risks on business; Exhibits119: Companies covered; Exhibits120: Matrix on companies position and classification; Exhibits121: AbbVie Inc. - Overview; Exhibits122: AbbVie Inc. - Product / Service; Exhibits123: AbbVie Inc. - Key news; Exhibits124: AbbVie Inc. - Key offerings; Exhibits125: Aenova Holding GmbH - Overview; Exhibits126: Aenova Holding GmbH - Product / Service; Exhibits127: Aenova Holding GmbH - Key offerings; Exhibits128: Boehringer Ingelheim International GmbH - Overview; Exhibits129: Boehringer Ingelheim International GmbH - Product / Service; Exhibits130: Boehringer Ingelheim International GmbH - Key news; Exhibits131: Boehringer Ingelheim International GmbH - Key offerings; Exhibits132: Catalent Inc. - Overview; Exhibits133: Catalent Inc. - Business segments; Exhibits134: Catalent Inc. - Key offerings; Exhibits135: Catalent Inc. - Segment focus; Exhibits136: Corden Pharma International GmbH - Overview; Exhibits137: Corden Pharma International GmbH - Product / Service; Exhibits138: Corden Pharma International GmbH - Key offerings; Exhibits139: Jubilant Pharmova Ltd. - Overview; Exhibits140: Jubilant Pharmova Ltd. - Business segments; Exhibits141: Jubilant Pharmova Ltd. - Key news; Exhibits142: Jubilant Pharmova Ltd. - Key offerings; Exhibits143: Jubilant Pharmova Ltd. - Segment focus; Exhibits144: Lonza Group Ltd. - Overview; Exhibits145: Lonza Group Ltd. - Business segments; Exhibits146: Lonza Group Ltd. - Key news; Exhibits147: Lonza Group Ltd. - Key offerings; Exhibits148: Lonza Group Ltd. - Segment focus; Exhibits149: Merck KGaA - Overview; Exhibits150: Merck KGaA - Business segments; Exhibits151: Merck KGaA - Key news; Exhibits152: Merck KGaA - Key offerings; Exhibits153: Merck KGaA - Segment focus; Exhibits154: NextPharma GmbH - Overview; Exhibits155: NextPharma GmbH - Product / Service; Exhibits156: NextPharma GmbH - Key offerings; Exhibits157: Perkin Elmer Inc. - Overview; Exhibits158: Perkin Elmer Inc. - Business segments; Exhibits159: Perkin Elmer Inc. - Key news; Exhibits160: Perkin Elmer Inc. - Key offerings; Exhibits161: Perkin Elmer Inc. - Segment focus; Exhibits162: Piramal Enterprises Ltd. - Overview; Exhibits163: Piramal Enterprises Ltd. - Product / Service; Exhibits164: Piramal Enterprises Ltd. - Key offerings; Exhibits165: Pyramid Laboratories Inc. - Overview; Exhibits166: Pyramid Laboratories Inc. - Product / Service; Exhibits167: Pyramid Laboratories Inc. - Key offerings; Exhibits168: Recipharm AB - Overview; Exhibits169: Recipharm AB - Business segments; Exhibits170: Recipharm AB - Key offerings; Exhibits171: Recipharm AB - Segment focus; Exhibits172: Siegfried Holding AG - Overview; Exhibits173: Siegfried Holding AG - Business segments; Exhibits174: Siegfried Holding AG - Key offerings; Exhibits175: Siegfried Holding AG - Segment focus; Exhibits176: Thermo Fisher Scientific Inc. - Overview; Exhibits177: Thermo Fisher Scientific Inc. - Business segments; Exhibits178: Thermo Fisher Scientific Inc. - Key news; Exhibits179: Thermo Fisher Scientific Inc. - Key offerings; Exhibits180: Thermo Fisher Scientific Inc. - Segment focus; Exhibits181: Inclusions checklist; Exhibits182: Exclusions checklist; Exhibits183: Currency conversion rates for US$; Exhibits184: Research methodology; Exhibits185: Information sources; Exhibits186: Data validation; Exhibits187: Validation techniques employed for market sizing; Exhibits188: Data synthesis; Exhibits189: 360 degree market analysis; Exhibits190: List of abbreviations